These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2528838)

  • 1. [Calcium inhibitors and cardioprotection].
    Gosse P; Dallocchio M
    Therapie; 1989; 44(3):209-13. PubMed ID: 2528838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of antihypertensive therapy on hypertensive heart disease.
    Messerli FH; Kaesser UR; Losem CJ
    Circulation; 1989 Dec; 80(6 Suppl):IV145-50. PubMed ID: 2532079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular structural changes in hypertension: possible regression during long-term antihypertensive treatment.
    Novo S; Abrignani MG; Corda M; Strano A
    Eur Heart J; 1991 Dec; 12 Suppl G():47-52. PubMed ID: 1839619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of calcium entry blockade on hypertension-induced left ventricular hypertrophy.
    Frishman WH; Skolnick AE; Strom JA
    Circulation; 1989 Dec; 80(6 Suppl):IV151-61. PubMed ID: 2532080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Calcium channel blocker and cardiac hypertrophy].
    Takeda T; Otsu K; Hori M
    Clin Calcium; 2005 Oct; 15(10):1645-9. PubMed ID: 16199909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of myocardial and coronary effects of arterial hypertension].
    Strauer BE; Motz W; Vogt M
    Z Kardiol; 1989; 78 Suppl 7():231-8. PubMed ID: 2533767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium antagonists and cardiovascular disorders.
    Krikler DM
    Ann Cardiol Angeiol (Paris); 1984 Dec; 33(8):513-8. PubMed ID: 6241445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium-channel blockers for combined systemic hypertension and myocardial ischemia.
    Frishman WH; Charlap S
    Circulation; 1987 Jun; 75(6 Pt 2):V154-62. PubMed ID: 3552312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S; Bakir SE
    Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Organ protection and regression of hypertension by calcium antagonists].
    Michel D
    Fortschr Med; 1991 Feb; 109(5):125-8. PubMed ID: 1828451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic regression of cardiac hypertrophy in experimental hypertension.
    Pfeffer MA; Pfeffer JM
    J Cardiovasc Pharmacol; 1984; 6 Suppl 6():S865-9. PubMed ID: 6084141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Differential therapy with calcium antagonists].
    Scholze JE
    Herz; 2003 Dec; 28(8):754-63. PubMed ID: 14689111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Are all antihypertensive drugs renoprotective?].
    Wolf S; Risler T
    Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [High blood pressure and coronary heart disease. Are there new therapeutic options?].
    Motz W
    Herz; 2004 May; 29(3):255-65. PubMed ID: 15167951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression of cardiac hypertrophy during long term calcium antagonist treatment with tiapamil.
    Ding YA; Huan R; Hsiung MC; Shieh SM
    J Hum Hypertens; 1989 Aug; 3(4):239-43. PubMed ID: 2529374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of calcium channel blockers in hypertension.
    Conlin PR; Williams GH
    Adv Intern Med; 1998; 43():533-62. PubMed ID: 9506192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Retrospective studies and prospects of therapy for hypertension].
    Maisch B; Brilla C; Kruse T; Noll B; Bethge C
    Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [ACE-inhibitors and cardiovascular protection].
    Agabiti-Rosei E; Muiesan ML
    Cardiologia; 1994 Dec; 39(12 Suppl 1):139-47. PubMed ID: 7634257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of sympathetic nervous activity on regression of cardiac hypertrophy.
    Strauer BE; Bayer F; Brecht HM; Motz W
    J Hypertens Suppl; 1985 Dec; 3(4):S39-44. PubMed ID: 2937889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.